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Mycoplasma pneumoniae is an important cause of community-acquired pneumonia (CAP). In this study,M. pneumoniae
strains in PCR-positive specimens collected from patients in Sydney, Australia (30 samples), and Beijing, China (83 samples),
were characterized using multilocus variable-number tandem-repeat (VNTR) analysis (MLVA), P1-restriction fragment length
polymorphism (RFLP) analysis, and sequencing of domain V of the 23S rRNA gene to compare genotype distribution andmac-
rolide resistance rates between locations. Eighteen distinct MLVA types were identified in specimens from Sydney, of which 10
were known (types E, G, J, M, N, P, U, V, S, and X) and 8 previously unknown. Strains were equally distributed between P1-RFLP
type 1 and type 2 variants. Among samples from Beijing, MLVA types E, G, J, P, U, X, and Z and four new types were identified.
Most specimens belonged to P1-RFLP type 1. A nomenclature based on five VNTR loci is proposed to designate MLVA patterns.
Macrolide resistance-associated mutations were identified in only 1 of 30 specimens (3.3%) from Sydney and 71 of 83 (85.5%)
from Beijing (P< 0.05). This study demonstrated that although multiple individualM. pneumoniae strains were circulating in
Beijing, the genotypes were less diverse than those in Sydney. However, the greatest regional difference was in the incidence of
macrolide resistance, which may reflect differences in antibiotic use and/or measures in resistance control.
Mycoplasma pneumoniae is an important pathogen causingcommunity-acquired pneumonia (CAP), especially in chil-
dren and young adults (1, 2). M. pneumoniae infections are in-
creasingly recognized epidemically worldwide and as being en-
demic to some regions (3, 4). Previous reports showed regional
differences in molecular profiles of M. pneumoniae (3, 5–7).
Knowledge of these molecular characteristics is essential for out-
break investigation and to monitor the epidemiology ofM. pneu-
moniae infections.
For the past 20 years, P1 gene restriction fragment length poly-
morphism (P1-RFLP) has been themost commonmolecular typ-
ing method for M. pneumoniae (8–10). Recombination events at
two repetitive sequence loci, RepMP2/3 and RepMP4, (11) in the
P1 gene contribute to gene variation, as reflected in sequence vari-
ants and subtypes, but the discriminatory power of this method is
limited (12–14). Recently, a multilocus variable-number tandem-
repeat (VNTR) analysis (MLVA) method was developed by
Dégrange et al. for M. pneumoniae isolates; this has a higher dis-
criminatory power and can differentiate more than 26 distinct
types (15). A culture-independent MLVAmethod for use directly
from clinical specimens has also been described (7). Macrolide-
resistantM. pneumoniae clinical isolates were first reported in the
1990s, and the incidence has been increasing ever since, with var-
ious rates in different geographic regions (16–20).
In this study, we usedMLVA, P1-RFLP analysis, and detection
of macrolide resistance-associated mutations to compare charac-
teristics of M. pneumoniae detected by PCR in clinical specimens
from Beijing, China, and Sydney, Australia.
MATERIALS AND METHODS
Clinical specimens. Thirty M. pneumoniae PCR-positive clinical speci-
mens, collected between 2008 and 2012 from patients aged between 2 and
70 years old, were obtained for further study from the diagnostic labora-
tory at the Centre for Infectious Diseases and Microbiology Laboratory
Services (CIDMLS), Institute of Clinical Pathology andMedical Research,
WestmeadHospital, Sydney, Australia. During the same 5-year period, 83
M. pneumoniae PCR-positive clinical specimens were obtained from pe-
diatric patients in the Affiliated Children’s Hospital of the Capital Insti-
tute of Pediatrics in Beijing.
Positive samples were identified using real-time PCR as described pre-
viously (21); only one sample from each patient was included. Specimen
types included sputum, throat swabs, nasopharyngeal swabs or aspirates,
bronchoalveolar lavage fluid (BALF), and pleural fluids. DNA was ex-
tracted using the QIAampDNAminikit (Qiagen) or the NucliSENS easy-
MAG (bioMérieux) according to themanufacturer’s instructions andwas
immediately used for PCR detection. M. pneumoniae-positive DNA ex-
tracts were stored at20°C until required for genotyping.
MLVA typing. MLVA was based on the five tandem repeat loci de-
scribed by Dégrange et al. (15). Numbers of repeats were determined by
sequencing. The MLVA loci were amplified with primers described pre-
viously (7) using a nested multiplex PCR to increase specificity. Briefly,
the nested PCR was performed using 2 HotStar Taq master mix
(Qiagen) in a 25-l reactionmixture containing 12.5l of the 2Qiagen
master mix, 0.5 l of each forward and reverse primer (10 mol/liter), 1
l extracted DNA, and 10.5 l of molecular-grade water. The PCR was
performed at 95°C for 10min, followed by 35 cycles of 95°C for 30 s, 55°C
for 30 s, and 72°C for 1 min and then a final extension of 72°C for 10min.
The amplified products were purified using ExoStar PCR and a sequenc-
ing cleanup kit (GE Healthcare), as instructed by the manufacturer, and
sequenced using an ABI 3730xl DNA analyzer (Applied Biosystems).
The MLVA types were assigned according to the nomenclature de-
scribed by Dégrange et al. (15) using letters as MLVA types. The numbers
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of repeats at each of the five loci were linked together in a digital format in
the orderMpn1-Mpn13-Mpn14-Mpn15-Mpn16 to designateMLVApat-
terns, e.g., 8-3-5-7-2.
P1 gene typing. P1 genotyping was performed by PCR amplification
of theRepMP4 andRepMP2/3 elements of the P1 gene. The PCRproducts
were cut with restriction enzyme HaeIII. The digested fragments were
separated using agarose gel electrophoresis, and patterns were interpreted
as previously described (10). The P1 types were confirmed by sequencing
and compared to reference sequences by performing BLAST searches in
GenBank (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Detection of macrolide resistance-associated mutations.Macrolide
resistance-associated mutations in domain V of the 23S rRNA gene were
detected using nested PCR-linked capillary electrophoresis and single-
strand conformation polymorphisms (nPCR-CE-SSCP) as previously de-
scribed by our group (20).
Data analysis. MLVA types were analyzed based on the difference in
numbers of repeats identified at each of the five loci. The repeat numbers
were recorded and imported into the Bionumerics software (version 5.0;
Applied Maths) to perform the dendrogram and the minimum spanning
tree (MST) analysis. The dendrogram was generated based on the cate-
gorical coefficient and an unweighted-pair group method using average
linkages (UPGMA) algorithm. The MST analysis was performed on the
categorical coefficient with a priority rule of the first link types set as the
highest number of single-locus variants (SLVs).
RESULTS
Molecular profiles of M. pneumoniae in respiratory specimens
from Sydney. Eighteen MLVA types, each represented by one to
three specimens, were identified among 30 samples from Sydney
patients. Of these, 10 were knownMLVA types (E, G, J,M, N, P, S,
U, V, andX) based on theDégrange nomenclature, represented by
21 (70%) specimens; eight types could not be assigned accord-
ing to this nomenclature. All genotypes were represented using
the proposed five-digit MLVA patterns. In one sample Mpn13
was not amplified, giving the profile 3-0-5-7-2. Mpn1 pro-
duced the most variable-repeat numbers of all loci, ranging
from two to nine; the remaining four loci were less variable.
When Mpn1 was excluded, three major MLVA clusters were
identified: 3-5-6-2 (12 specimens, six MLVA types), 3-5-7-2 (5
specimens, four MLVA types), and 4-5-7-2 (10 specimens, five
MLVA types) (Fig. 1).
There were four P1-RFLP genotypes among 30 samples: 15
of type 1, 7 each of types 2a and 2c, and 1 of type 2b. No obvious
correlation between P1-RFLP and MLVA types was identified,
and there was no apparent temporal clustering of either MLVA
or P1-RFLP types during the period of specimen collection
(Fig. 1).
Sequencing of domain V of the 23S rRNA gene identified a
macrolide resistance-associated mutation (A2064G) in one spec-
imen (3.3%).
Molecular profiles of M. pneumoniae in respiratory speci-
mens from Beijing. There were 11 MLVA types among 83 speci-
mens, of which seven were previously known types (E, G, J, P, U,
FIG 1 Molecular profiles of 30M. pneumoniae samples collected between 2009 and 2012 from Sydney, Australia. The dendrogram was generated based on the
variable-number tandem repeats according to our five-digit MLVA pattern (see the text). MLVA type was also assigned according to the Dégrange scheme (15);
asterisks show MLVA types not found in the scheme. MRA, macrolide resistance associated.
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X, and Z), based on the Dégrange nomenclature; they accounted
for 76 (91.6%) specimens; of these, the four types U (24), X (19),
P (16), and J (8) accounted for 80.7%of specimens. The other four
were novel MLVA types. Most specimens (78; 93.9%) shared a
common pattern at the last four loci, 4-5-7-2, including seven
MLVA types that clustered together in the dendrogram (Fig. 2). In
one specimen, locus Mpn1was not amplified (profile 0-2-5-5-2).
In the P1-RFLP analysis, 80 (96.4%) of samples contained type
1, and the remainder contained type 2c (Fig. 2).
Macrolide resistancemutations were identified in domain V of
the 23S rRNA gene in 71 specimens (85.5%), of which 68 were
A2063G and three A2063C; they occurred throughout the 5-year
period. There was no correlation between MLVA types and mac-
rolide resistance (Fig. 2).
Comparison of molecular features between samples from
Beijing and Sydney. The genetic relationships of all 113 samples
fromBeijing, China, and Sydney, Australia, were analyzed by con-
struction of anMST using Bionumerics software (AppliedMaths)
(Fig. 3). At locus three (Mpn14), there were five repeats in all
samples tested. In contrast, there were major differences at the
second locus (Mpn13), which, with a few exceptions, grouped
MLVA patterns into clusters between and among samples from
Beijing and Sydney. The majority of samples from Sydney had
three repeats at Mpn13, and the most common pattern was 3-5-
6(7)-2, whereas most samples from Beijing had four repeats, with
themost common pattern being 4-5-7-2(3).MLVApattern diver-
sity among samples was highlighted by the MST, with the first
locus (Mpn1) being themost diversemarker that subdivided clus-
ters at both geographic locations. There was a marked difference
in prevalence of macrolide resistance mutations between samples
from Beijing and Sydney (chi square 86.1, P 0.05), which was
found in all of BeijingMLVApatterns but in only one fromSydney
(Fig. 1, 2, and 3).
DISCUSSION
M. pneumoniae activity that is endemic to certain regions occurs
with periodic prolonged epidemics or periods of increased activity
that are separated by a few years (3, 4, 6). Molecular typing is
required to determine whether periods of increased activity are
true epidemics due to the spread of a predominant strain or in-
creases in the prevalence of several strains.
In 2007, Degrange et al. described an MLVA method for M.
pneumoniae based on fiveVNTR loci which they used to study 265
isolates, mainly from France, collected over about a decade. They
identified 26 differentMLVApatterns, which they designated A to
Z, based on five-digit codes representing the numbers of repeats at
each locus. Five MLVA types, P, U, O, J, and E, accounted for
nearly 60% of isolates (15). Since then, several studies have shown
different combinations of generally four to six predominant
strains circulating simultaneously (3, 5–7) and changing over time
(22). Most studies indicate that periods of apparent epidemic ac-
tivity generally are not due to single epidemic strains (3, 6, 22).
However, true epidemics can occur; Pereyre et al. reported an
outbreak of M. pneumoniae infections due to clonal spread of a
single strain among children attending a primary school and their
household contacts (23).
Our results confirmed that Mpn1 was the most variable lo-
cus, as reported by Benitez et al., who demonstrated multiple
insertions or deletions of tandem repeats within this locus (5).
Excluding this locus, MLVA types in studies reported from
Europe and the United States have shown two predominant
patterns for the last four repeats, namely4-5-7-2(3) and3-
5-6(7)-2. In our study, there are 11 MLVA types in pattern
4-5-7-2(3) and 17 MLVA types in pattern 3-5-6(7)-2. These
FIG 2 Molecular profiles of 83 M. pneumoniae samples collected between
2009 and 2012 from Beijing, China. The dendrogram was generated based on
the variable-number tandem repeats according to our five-digitMLVApattern
(see the text).MLVA type was also assigned according to the Dégrange scheme
(15); asterisks show MLVA types not found in the scheme. MRA, macrolide
resistance associated.
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MLVA types are shared by 93.3% of Sydney specimens (28/30).
(Fig. 1). There was less diversity among Beijing specimens;
most MLVA types shared the pattern 4-5-7-2, representing
seven MLVA types and 93.9% of specimens (Fig. 2). This is
consistent with the findings of another study from Beijing, in
which 175 (87.1%) and 15 (7.5%) of 201 specimens contained
MLVA patterns 4-5-7-2 and 3-5-6-2, respectively (24).
On the other hand, the most variable locus, Mpn1, has an
important role in the investigation of local epidemics due to its
high discriminatory power. A previous report showed repeat
numbers ranging from one to eight (5). In this study, we iden-
tified one specimen with nine repeats at Mpn1 and one in
which it failed to amplify, suggesting the potential variation at
this locus is even greater. It is possible that this variation could
be used to investigate outbreaks in small settings, such as
schools or hospitals.
Until 2009, P1-RFLP typing was the main genotypingmethod.
It has become a marker of gene evolution due to its low discrimi-
nation power. In this study, most specimens from China were
identified as P1 type 1, and only three (3.6%) were P1 type 2c.
Zhao et al. (24) also found that a majority of specimens from
Beijing were P1 type 1, whereas in Sydney specimens were evenly
divided between type 1 and type 2 variants, as described in Euro-
pean countries and the United States (4, 5, 15).
The other major difference was a much higher rate of macrolide
resistance mutations in Beijing (85.5%) than in Sydney (3.3%),
which has been described in other studies from Asia (18, 25, 26). In
common with Zhao et al., we found no correlation between MLVA
type andmacrolide resistance (24).Asmost strains fromBeijingwere
P1 type 1, we cannot infer that P1-RFLP type 1 strains were more
likely to acquire macrolide resistance. The high rate of macrolide re-
sistance in Chinamore likely is related to excessive use of antibiotics.
Further studies are needed to identify relatedness, if any, between
macrolide resistance and genotype.
In conclusion, there were regional differences in molecular
profiles of M. pneumoniae from specimens obtained in Sydney
and Beijing, but these should be interpreted with caution as the
patient populations were different (a wide age range among Syd-
ney patients but only children in Beijing). MLVA typing is far
more discriminatory than P1 gene subtyping, which makes it
more useful for epidemiological studies and comparisons between
regions. Alternative molecular typing methods, including whole-
genome sequencing, may provide a better understanding of the
molecular characteristics ofM. pneumoniae.
FIG 3 Minimum spanning tree (MST) analysis of molecular features of 113 M. pneumoniae samples from Beijing, China, and Sydney, Australia. Each circle
represents a particularMLVA profile, designated byMLVA pattern andDégrange type in parentheses (*, novelMLVA type). The color of the circles corresponds
to sample source: white for Beijing, China, and gray for Sydney, Australia. R indicates the presence of macrolide resistance, and the number in parentheses
indicates the number of the resistant samples out of the total in a particularMLVA type. The size of the circle is proportional to the number of samples belonging
to the indicatedMLVA type. The distance between neighboringMLVA types is expressed as the number of allelic changes and is indicated by 1, 2, and 3 for one,
two, and three changes, respectively.
Molecular Characterizations of M. pneumoniae
May 2014 Volume 52 Number 5 jcm.asm.org 1481
 o
n
 January 19, 2015 by UNIV O
F SYDNEY
http://jcm.asm.org/
D
ow
nloaded from
 
ACKNOWLEDGMENTS
This work was supported by the Beijing Natural Science Foundation
(7112019) and the Beijing City talent training project fund (20071
A0303200118).
REFERENCES
1. Hammerschlag MR. 2001. Mycoplasma pneumoniae infections.
Curr. Opin. Infect. Dis. 14:181–186. http://dx.doi.org/10.1097/00001432
-200104000-00012.
2. Waites KB, Atkinson TP. 2009. The role of Mycoplasma in upper respi-
ratory infections. Curr. Infect. Dis. Rep. 11:198–206. http://dx.doi.org/10
.1007/s11908-009-0030-6.
3. Pereyre S, Charron A, Hidalgo-Grass C, Touati A, Moses AE, Nir-Paz
R, Bébéar C. 2012. The spread ofMycoplasma pneumoniae is polyclonal in
both an endemic setting in France and in an epidemic setting in Israel.
PLoS One 7:e38585. http://dx.doi.org/10.1371/journal.pone.0038585.
4. Lenglet A, Herrador Z, Magiorakos AP, Leitmeyer K, Coulombier D.
2012. Surveillance status and recent data forMycoplasma pneumoniae in-
fections in the European Union and European Economic Area, January
2012. Euro Surveill. 17:20075. http://www.eurosurveillance.org/View
Article.aspx?ArticleId20075.
5. Benitez AJ, Diaz MH, Wolff BJ, Pimentel G, Njenga MK, Estevez A,
Winchell JM. 2012. Multilocus variable-number tandem-repeat analysis
of Mycoplasma pneumoniae clinical isolates from 1962 to the present: a
retrospective study. J. Clin. Microbiol. 50:3620–3626. http://dx.doi.org
/10.1128/JCM.01755-12.
6. Chalker V, Stocki T, Litt D, Bermingham A, Watson J, Fleming D,
Harrison T. 2012. Increased detection of Mycoplasma pneumoniae infec-
tion in children in England and Wales, October 2011 to January 2012.
Euro Surveill. 17:20081. http://www.eurosurveillance.org/ViewArticle
.aspx?ArticleId20081.
7. Dumke R, Jacobs E. 2011. Culture-independent multi-locus variable-
number tandem-repeat analysis (MLVA) of Mycoplasma pneumoniae. J.
Microbiol. Methods 86:393–396. http://dx.doi.org/10.1016/j.mimet.2011
.06.008.
8. Cousin-Allery A, Charron A, de Barbeyrac B, Fremy G, Skov Jensen
J, Renaudin H, Bebear C. 2000. Molecular typing of Mycoplasma
pneumoniae strains by PCR-based methods and pulsed-field gel electro-
phoresis. Application to French and Danish isolates. Epidemiol. Infect.
124:103–111. (http://journals.cambridge.org/action/displayAbstract?fro
mPageonline&aid40019&fulltextTypeRA&fileIdS095026889900
3313).
9. Kenri T, Okazaki N, Yamazaki T, Narita M, Izumikawa K, Matsuoka M,
Suzuki S, Horino A, Sasaki T. 2008. Genotyping analysis of Mycoplasma
pneumoniae clinical strains in Japan between 1995 and 2005: type shift
phenomenon of M. pneumoniae clinical strains. J. Med. Microbiol. 57:
469–475. http://dx.doi.org/10.1099/jmm.0.47634-0.
10. Sasaki T, Kenri T, Okazaki N, Iseki M, Yamashita R, Shintani M, Sasaki
Y, Yayoshi M. 1996. Epidemiological study of Mycoplasma pneumoniae
infections in Japan based on PCR-restriction fragment length polymor-
phism of the P1 cytadhesin gene. J. Clin. Microbiol. 34:447–449.
11. Kenri T, Taniguchi R, Sasaki Y, Okazaki N, Narita M, Izumikawa K,
Umetsu M, Sasaki T. 1999. Identification of a new variable sequence in
the P1 cytadhesin gene ofMycoplasma pneumoniae: evidence for the gen-
eration of antigenic variation by DNA recombination between repetitive
sequences. Infect. Immun. 67:4557–4562.
12. Dumke R, Lück PC, Noppen C, Schaefer C, von Baum H, Marre R,
Jacobs E. 2006. Culture-independentmolecular subtyping ofMycoplasma
pneumoniae in clinical samples. J. Clin. Microbiol. 44:2567–2570. http:
//dx.doi.org/10.1128/JCM.00495-06.
13. Dorigo-Zetsma JW, Wilbrink B, Dankert J, Zaat SA. 2001. Mycoplasma
pneumoniae P1 type 1- and type 2-specific sequences within the P1 cytad-
hesin gene of individual strains. Infect. Immun. 69:5612–5618. http://dx
.doi.org/10.1128/IAI.69.9.5612-5618.2001.
14. Zhao F, Cao B, Li J, Song S, Tao X, Yin Y, He L, Zhang J. 2011. Sequence
analysis of the P1 adhesin gene of Mycoplasma pneumoniae in clinical
isolates collected in Beijing in 2008 to 2009. J. Clin. Microbiol. 49:3000–
3003. http://dx.doi.org/10.1128/JCM.00105-11.
15. Dégrange S, Cazanave C, Charron A, Renaudin H, Bébéar C, Bébéar
CM. 2009. Development of multiple-locus variable-number tandem-
repeat analysis for molecular typing of Mycoplasma pneumoniae. J. Clin.
Microbiol. 47:914–923. http://dx.doi.org/10.1128/JCM.01935-08.
16. Okazaki N, Narita M, Yamada S, Izumikawa K, Umetsu M, Kenri T,
Sasaki Y, Arakawa Y, Sasaki T. 2001. Characteristics of macrolide-
resistant Mycoplasma pneumoniae strains isolated from patients and in-
duced with erythromycin in vitro. Microbiol. Immunol. 45:617–620.
http://dx.doi.org/10.1111/j.1348-0421.2001.tb01293.x.
17. Peuchant O, Ménard A, Renaudin H, Morozumi M, Ubukata K, Bébéar
CM, Pereyre S. 2009. Increasedmacrolide resistance ofMycoplasma pneu-
moniae in France directly detected in clinical specimens by real-time PCR
and melting curve analysis. J. Antimicrob. Chemother. 64:52–58. http:
//dx.doi.org/10.1093/jac/dkp160.
18. Liu Y, Ye X, Zhang H, Xu X, Wang M. 2012. Multiclonal origin of
macrolide-resistant Mycoplasma pneumoniae isolates as determined by
multilocus variable-number tandem-repeat analysis. J. Clin. Microbiol.
50:2793–2795. http://dx.doi.org/10.1128/JCM.00678-12.
19. Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K,
Suzuki I, Andoh T, Kenri T, Sasaki Y, Horino A, Shintani M, Arakawa
Y, Sasaki T. 2004. Characterization and molecular analysis of macrolide-
resistantMycoplasma pneumoniae clinical isolates obtained in Japan. An-
timicrob. Agents Chemother. 48:4624–4630. http://dx.doi.org/10.1128
/AAC.48.12.4624-4630.2004.
20. Lin C, Li S, Sun H, Zhao H, Feng Y, Cao L, Yuan Y, Zhang T. 2010.
Nested PCR-linked capillary electrophoresis and single-strand conforma-
tion polymorphisms for detection of macrolide-resistant Mycoplasma
pneumoniae in Beijing. J. Clin. Microbiol. 48:4567–4572. http://dx.doi
.org/10.1128/JCM.00400-10.
21. Dumke R, Schurwanz N, Lenz M, Schuppler M, Lück C, Jacobs E. 2007.
Sensitive detection ofMycoplasma pneumoniae in human respiratory tract
samples by optimized real-time PCR approach. J. Clin. Microbiol. 45:
2726–2730. http://dx.doi.org/10.1128/JCM.00321-07.
22. Pereyre S, Touati A, Petitjean-Lecherbonnier J, Charron A, Vabret A,
Bébéar C. 2013. The increased incidence of Mycoplasma pneumoniae in
France in 2011 was polyclonal, mainly involving M. pneumoniae type 1
strains. Clin. Microbiol. Infect. 19:E212–E217. http://dx.doi.org/10.1111
/1469-0691.12107.
23. Pereyre S, Renaudin H, Charron A, Bébéar C. 2012. Clonal spread of
Mycoplasma pneumoniae in primary school, Bordeaux, France. Emerg.
Infect. Dis. 18:343–345. http://dx.doi.org/10.3201/eid1802.111379.
24. Zhao F, Liu G, Cao B, Wu J, Gu Y, He L, Meng F, Zhu L, Yin Y, Lv M,
Zhang J. 2013.Multiple-locus variable-number tandem-repeat analysis of
201Mycoplasma pneumoniae isolates fromBeijing in 2008 to 2011. J. Clin.
Microbiol. 51:636–639. http://dx.doi.org/10.1128/JCM.02567-12.
25. Sun H, Xue G, Yan C, Li S, Cao L, Yuan Y, Zhao H, Feng Y, Wang L,
Fan Z. 2013. Multiple-locus variable-number tandem-repeat analysis of
Mycoplasma pneumonia clinical specimens and proposal for amendment
of MLVA nomenclature. PLoS One 8:e64607. http://dx.doi.org/10.1371
/journal.pone.0064607.
26. Suzuki Y, Itagaki T, Seto J, Kaneko A, Abiko C, Mizuta K, Matsuzaki Y.
2013. Community outbreak of macrolide-resistant Mycoplasma pneu-
moniae in Yamagata, Japan in 2009. Pediatr. Infect. Dis. J. 32:237–240.
http://dx.doi.org/10.1097/INF.0b013e31827aa7bd.
Xue et al.
1482 jcm.asm.org Journal of Clinical Microbiology
 o
n
 January 19, 2015 by UNIV O
F SYDNEY
http://jcm.asm.org/
D
ow
nloaded from
 
